These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2228105)

  • 1. Complex mixtures and cancer risk.
    IARC Sci Publ; 1990; (104):1-8. PubMed ID: 2228105
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction between human carcinogens.
    Kaldor JM; L'Abbé KA
    IARC Sci Publ; 1990; (104):35-43. PubMed ID: 2228132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of human carcinogenic risks in IARC monographs].
    Vainio H; Wilbourn JD; Sasco AJ; Partensky C; Gaudin N; Heseltine E; Eragne I
    Bull Cancer; 1995; 82(5):339-48. PubMed ID: 7626841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Toxicological basis for evaluating health risk].
    Rolecki R; Dutkiewicz T; Kończalik J
    Med Pr; 1992; 43(3):173-81. PubMed ID: 1406237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
    Shields PG
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract]   [Full Text] [Related]  

  • 7. Man-made vitreous fibres.
    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
    IARC Monogr Eval Carcinog Risks Hum; 2002; 81():1-381. PubMed ID: 12458547
    [No Abstract]   [Full Text] [Related]  

  • 8. What are the major carcinogens in the etiology of human cancer? Industrial carcinogens.
    Perera FP; Boffetta P; Nisbet IC
    Important Adv Oncol; 1989; ():249-65. PubMed ID: 2651292
    [No Abstract]   [Full Text] [Related]  

  • 9. Complex mixtures and cancer risk.
    IARC Sci Publ; 1990; (104):1-433. PubMed ID: 2228104
    [No Abstract]   [Full Text] [Related]  

  • 10. The instability of tumor promotion in relation to human cancer risk.
    Pitot HC; Dragan YP
    Prog Clin Biol Res; 1995; 391():21-38. PubMed ID: 8532718
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovering carcinogens in the occupational environment: a novel epidemiologic approach.
    Siemiatycki J; Day NE; Fabry J; Cooper JA
    J Natl Cancer Inst; 1981 Feb; 66(2):217-25. PubMed ID: 6935472
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiologic identification of occupational carcinogens.
    Armstrong B
    Cancer Detect Prev; 1981; 4(1-4):1-7. PubMed ID: 7349766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A carcinogens--methods for detecting environmental muta/carcinogens].
    Morimoto K; Koizumi A
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):789-97. PubMed ID: 3885860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental cancer in the Indian context--an overview.
    Krishna Murti CR
    Indian J Cancer; 1989 Jun; 26(2):102-14. PubMed ID: 2687161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomonitoring Equivalents (BE) dossier for trihalomethanes.
    Aylward LL; LaKind JS; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S68-77. PubMed ID: 18579267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrective measures and occupational carcinogens.
    Simonato L
    Cancer Detect Prev; 1982; 5(4):381-4. PubMed ID: 7182066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airborne carcinogens and human cancer.
    Kaplan SD; Morgan RW
    Rev Environ Health; 1981; 3(4):329-68. PubMed ID: 6762629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of short-term tests in detecting carcinogenicity of complex mixtures.
    Anderson D
    IARC Sci Publ; 1990; (104):89-100. PubMed ID: 2228146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exposure to chemical carcinogens in Poland in 1999].
    Konieczko K; Czerczak S; Kluszczyński D
    Med Pr; 2001; 52(6):395-400. PubMed ID: 11928668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a comparative potency method for cancer risk assessment of complex mixtures using short-term in vivo and in vitro bioassays.
    Lewtas J
    Toxicol Ind Health; 1985 Dec; 1(4):193-203. PubMed ID: 3843500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.